We identified that the ratios of PD-L1, PD-L2, and CD276 transcripts in relation to ICOS transcripts are independent predictors of the outcomes in node-positive OSCC and HNSCC. This evidence concerns the gene PDCD1LG2 and head and neck squamous cell carcinoma.